9-114062688-G-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The ENST00000265132.8(AMBP):c.674C>A(p.Thr225Asn) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000342 in 1,461,534 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
ENST00000265132.8 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
AMBP | NM_001633.4 | c.674C>A | p.Thr225Asn | missense_variant | 7/10 | ENST00000265132.8 | NP_001624.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
AMBP | ENST00000265132.8 | c.674C>A | p.Thr225Asn | missense_variant | 7/10 | 1 | NM_001633.4 | ENSP00000265132.3 | ||
AMBP | ENST00000466610.6 | c.347C>A | p.Thr116Asn | missense_variant | 5/7 | 3 | ENSP00000475149.1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 exomes AF: 0.0000239 AC: 6AN: 251432Hom.: 0 AF XY: 0.0000221 AC XY: 3AN XY: 135884
GnomAD4 exome AF: 0.00000342 AC: 5AN: 1461534Hom.: 0 Cov.: 31 AF XY: 0.00000413 AC XY: 3AN XY: 727066
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | May 26, 2024 | The c.674C>A (p.T225N) alteration is located in exon 7 (coding exon 7) of the AMBP gene. This alteration results from a C to A substitution at nucleotide position 674, causing the threonine (T) at amino acid position 225 to be replaced by an asparagine (N). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at